Prevention & lipidsCohort study

From plasma triglycerides to triglyceride metabolism: effects on mortality in the Copenhagen General Population Study

Eur Heart JPublished

  • Prospective cohort study
  • nested within the Copenhagen General Population Study

Authors' conclusion

This study observed an increased risk of all-cause, cardiovascular, cancer, and other mortality with higher triglyceride metabolism. This was not explained by higher plasma triglycerides and body mass index.

Study context

Population
Individuals from the Copenhagen General Population Studynested within 109,751
Participants
30,000 individuals
Exposure
Highest vs lowest fourth of plasma glycerol and β-hydroxybutyrate
Outcome
All-cause mortality
Follow-up
Median 10.7 years

Main finding

As reported in the abstract

multivariable adjusted
HR
Glycerol >80 µmol/L vs Glycerol <52 µmol/L
1.31(95% CI 1.22–1.40)
β-hydroxybutyrate >154 µmol/L vs β-hydroxybutyrate <91 µmol/L
1.18(CI 1.11–1.26)

Observational data: associations, not effects.

Further findings

OutcomeHR (CI)
CV mortality — Glycerol >80 µmol/L vs Glycerol <52 µmol/L1.37 (1.18–1.59)
CV mortality — β-hydroxybutyrate >154 µmol/L vs β-hydroxybutyrate <91 µmol/L1.18 (1.03–1.35)
Cancer mortality — Glycerol >80 µmol/L vs Glycerol <52 µmol/L1.24 (1.11–1.39)
Cancer mortality — β-hydroxybutyrate >154 µmol/L vs β-hydroxybutyrate <91 µmol/L1.16 (1.05–1.29)
Other mortality — Glycerol >80 µmol/L vs Glycerol <52 µmol/L1.45 (1.28–1.66)
Other mortality — β-hydroxybutyrate >154 µmol/L vs β-hydroxybutyrate <91 µmol/L1.23 (1.09–1.39)
  • CV mortality: 2204 CV deaths
  • Cancer mortality: 3366 cancer deaths
  • Other mortality: 2745 deaths from other causes

Sensitivity analyses

Results robust to excluding first years of follow-up, to stratification for covariates incl. plasma TG and BMI, and to further adjustments

Original publication

From plasma triglycerides to triglyceride metabolism: effects on mortality in the Copenhagen General Population Study. Eur Heart J. Published 14 August 2023. doi:10.1093/eurheartj/ehad330

Summarised from the published abstract; every number is checked against it